Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Antiviral Therapy|March 1, 2012
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trialAdrian Curran, Esteban Martinez, Daniel Podzamczer, et al.
Expert Review of Anti-Infective Therapy|July 31, 2014
Switch strategies in antiretroviral therapy regimensEva Van den Eynde, Daniel Podzamczer
Expert Opinion on Drug Safety|May 2, 2020
Nothing is perfect: the safety issues of integrase inhibitor regimensSofía Scévola, Juan Manuel Tiraboschi, Daniel Podzamczer
Journal of Acquired Immune Deficiency Syndromes (1999)|August 14, 2010
Maraviroc concentrations in cerebrospinal fluid in HIV-infected patientsJuan Manuel Tiraboschi, Jordi Niubo, Jordi Curto, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Etravirine in highly treatment-experienced patients]Daniel Podzamczer Palter, Elena Ferrer Corbera, Juan Manuel Tiraboschi
The American Journal of Tropical Medicine and Hygiene|July 3, 2010
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patientPatricia Barragán, Rogelio López-Velez, Montserrat Olmo, et al.
Personalized Medicine|February 27, 2013
Clinical perspectives on human genetic screening to prevent nevirapine toxicityDavid W Haas, Piroon Mootsikapun, Kiat Ruxrungtham, et al.
Journal of Clinical Medicine|August 27, 2021
Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected PatientsMaria Saumoy, Jose Luís Sanchez-Quesada, Jordi Ordoñez-Llanos, et al.
Medicina Clinica|July 26, 2017
Extracutaneous atypical syphilis in HIV-infected patientsPaula Prieto, Arkaitz Imaz, Laura Calatayud, et al.
HIV Research & Clinical Practice|February 18, 2020
Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow upJuan Tiraboschi, Natalia Lattour, Hernando Knobel, et al.
Pageof 19